Investment syndicate, Archangels, is continuing to see a pipeline of innovative companies that provide confidence for the second half of the year.
David Ovens, joint managing director of the Edinburgh-based syndicate, said cotland’s early-stage investment market continues to demonstrate resilience.
In what was a challenging year globally, 2025 was a record year for Scotland, with a total of £1.15 billion raised. It has leveraged £17.9 million of investment in Scottish scale-ups in the first half of 2026, backing some of Scotland’s most promising early-stage technology and life science companies.
The total investment for the first half of 2026 includes £7.2m invested directly by Archangels’ members, alongside £10.7m of co-investment secured from partner investors.
Noting the success of Edinburgh university spin-outs Biocapiva and Bioliberty, Mr Ovens said: “The first half of 2026 has been another active period for Archangels, with the syndicate backing some genuinely exceptional companies.”
“Biocaptiva and Bioliberty are each addressing significant global challenges, and the quality of co-investment we’ve been able to attract alongside our members reflects just how compelling these opportunities are to the wider investor community.
“Scotland’s early-stage ecosystem continues to punch well above its weight, and while the macroeconomic backdrop remains uncertain, the pipeline of innovative companies coming through gives us real confidence, going into the second half of the year.
“Archangels has been backing Scotland’s best founders for over 30 years, and the ambition and quality we’re seeing today is as strong as it’s ever been.”
#Pipeline #innovation #lifts #confidence #Archangels #Daily #Business